Nataliia Glushko

666 citations
2 papers · 327 indexed · 1 hit paper · h-index 2
Topics
Cancer Immunotherapy and Biomarkers (1 paper)Immunotherapy and Immune Responses (1 paper)Chronic Myeloid Leukemia Treatments (1 paper)
Partner nations
UkraineSingapore

In The Last Decade

Nataliia Glushko

2 papers receiving 319 citations

Hit Papers

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Mye...20172026202020232017100200300

Peers

Nataliia Glushko
Comparison fields: 5 of 42
  • Hematology 275
  • Genetics 217
  • Rheumatology 120
  • Oncology 77
  • Molecular Biology 42
Replace Véronique Bédoucha with:
Véronique Bédoucha Switzerland
Fabian Lang Germany
Gioia Colafigli Italy
María Soledad Undurraga Chile
Juan Julio Kassack Ipiña Mexico
Arta Dreimane Sweden
Hyacinthe Johnson‐Ansah France
Alfonso Quintás-Cardama United States
Katy Knight United Kingdom
Uwe Schwindel Germany
Nataliia Glushko relative to Véronique Bédoucha Switzerland Véronique Bédoucha's profile →
Citations per field
00.5×1.5×1.8×
Véronique Bédoucha · 1×
Citations per year

Countries citing papers authored by Nataliia Glushko

Since Specialization
Citations

This map shows the geographic impact of Nataliia Glushko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nataliia Glushko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nataliia Glushko more than expected).

Fields of papers citing papers by Nataliia Glushko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nataliia Glushko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nataliia Glushko. The network helps show where Nataliia Glushko may publish in the future.

Co-authorship network of co-authors of Nataliia Glushko

This figure shows the co-authorship network connecting the top 25 collaborators of Nataliia Glushko. A scholar is included among the top collaborators of Nataliia Glushko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nataliia Glushko. Nataliia Glushko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
#WorkIndexed citations
1
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trialbreakdown →
320
2
Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma.
7

About Nataliia Glushko

Nataliia Glushko is a scholar working on Biotechnology, Genetics and Hematology, having authored 2 papers that have together received 327 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (1 paper), Immunotherapy and Immune Responses (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (275 citations), Genetics (217 citations) and Rheumatology (120 citations). Nataliia Glushko has collaborated with scholars based in Ukraine and Singapore. Frequent co-authors include Michael J. Mauro, Tim H. Brümmendorf, Charles Chuah, Philipp le Coutre, Allison Jeynes-Ellis, Michael W. Deininger, Iryna Dyagil, Valentín García‐Gutiérrez, Andreas Hochhaus and Dong‐Wook Kim. Their work appears in journals such as Journal of Clinical Oncology and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026